Increased expression of microRNA-155 in peripheral blood mononuclear cells from psoriasis patients is related to

S García-Rodríguez1, S Arias-Santiago2, G Blasco-Morente2

  • 1Department of Cellular Biology and Immunology, Instituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, Parque Tecnológico de la Salud de Granada (PTS Granada), Av. Conocimiento, 17, Granada-18016, Spain.

Abstract

Insights

Psoriasis patients show elevated levels of specific microRNAs (miRNAs) in blood and cells, which correlate with disease severity. Treatment reduces these miRNA levels, indicating their role in psoriasis pathogenesis and potential as biomarkers.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Immunology

Background:

  • MicroRNAs (miRNAs) are key gene regulators implicated in various diseases.
  • Altered miRNA expression is observed in psoriasis, suggesting their involvement in the condition's development.

Purpose of the Study:

  • To investigate the expression of inflammation and toll-like receptor (TLR)-related miRNAs in psoriasis patients.
  • To analyze changes in miRNA levels in peripheral blood mononuclear cells (PBMCs) and plasma before and after treatment.

Main Methods:

  • Quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) was used to measure miRNA expression.
  • Expression levels were analyzed in treatment-naive psoriasis patients and matched controls.

Main Results:

  • Psoriasis patients exhibited increased baseline expression of specific miRNAs (miRNA-155, let-7i, miRNA-21, miRNA-146a, miRNA-223) in PBMCs and plasma.
  • miRNA-155 expression in PBMCs correlated with Psoriasis Area Severity Index (PASI).
  • Treatment led to reduced PASI scores and modulated miRNA expression, with miRNA-155 decreasing and plasma miRNAs (miRNA-21, miRNA-146a, miRNA-223) down-regulating.

Conclusions:

  • Elevated miRNA-155 in PBMCs is linked to psoriasis severity and decreases with treatment remission.
  • Specific miRNAs (miRNA-21, miRNA-146a, miRNA-223) in PBMCs and plasma are upregulated at baseline and modulated by treatment.
  • These findings highlight the distinct roles of TLR-related miRNAs in psoriasis pathogenesis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K